PriceTargets.com logo

Zevia PBC - ZVIA Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $4.17
  • Forecasted Upside: 404.62%
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 4 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$0.83 As of 04/25/2024 01:00 AM ET
+0 (0.00%)

This chart shows the closing price for ZVIA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Zevia PBC Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ZVIA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ZVIA

Analyst Price Target is $4.17
▲ +404.62% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Zevia PBC in the last 3 months. The average price target is $4.17, with a high forecast of $8.00 and a low forecast of $2.00. The average price target represents a 404.62% upside from the last price of $0.83.

This chart shows the closing price for ZVIA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Hold

The current consensus among 6 polled investment analysts is to hold stock in Zevia PBC. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
11/2/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
1/31/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
5/1/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
7/30/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
10/28/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
1/26/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
4/25/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/28/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$3.00 ➝ $2.00Low
2/21/2024Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$4.00Low
11/8/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$3.25 ➝ $3.00Low
8/15/2023Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$4.00Low
8/9/2023Telsey Advisory GroupReiterated RatingMarket Perform ➝ Market Perform$4.00Low
8/9/2023BMO Capital MarketsLower TargetOutperform ➝ Outperform$8.00 ➝ $5.00Low
8/9/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$3.50 ➝ $3.25Low
7/25/2023StephensReiterated RatingOverweight ➝ Overweight$8.00Low
7/25/2023Wells Fargo & CompanyLower TargetEqual Weight$4.00 ➝ $3.00Low
7/25/2023The Goldman Sachs GroupDowngradeBuy ➝ Neutral$5.00 ➝ $3.00Low
7/25/2023Telsey Advisory GroupDowngradeOutperform ➝ Market Perform$5.00 ➝ $4.00Low
3/1/2023Telsey Advisory GroupLower TargetOutperform$5.50 ➝ $5.00Low
2/23/2023Telsey Advisory GroupReiterated RatingOutperform$5.50Low
11/11/2022StephensLower TargetOverweight$10.00 ➝ $8.00Low
11/11/2022Morgan StanleyLower TargetEqual Weight$3.75 ➝ $3.50Low
11/11/2022Wells Fargo & CompanyLower TargetEqual Weight$4.50 ➝ $4.00Low
11/11/2022Telsey Advisory GroupLower TargetOutperform$6.00 ➝ $5.50Low
10/4/2022Morgan StanleyBoost TargetEqual Weight$3.50 ➝ $3.75Low
10/3/2022Wells Fargo & CompanyBoost TargetEqual Weight$3.50 ➝ $4.50Low
8/15/2022Morgan StanleyBoost TargetEqual Weight$3.25 ➝ $3.50Low
4/4/2022The Goldman Sachs GroupLower TargetBuy$18.00 ➝ $16.00High
2/28/2022BMO Capital MarketsLower Target$18.00 ➝ $13.00Low
2/25/2022Telsey Advisory GroupLower TargetOutperform$14.00 ➝ $10.00Medium
11/15/2021Wells Fargo & CompanyDowngradeOverweight ➝ Equal Weight$16.00 ➝ $11.00High
11/15/2021Telsey Advisory GroupLower TargetOutperform$15.00 ➝ $14.00High
10/18/2021Loop CapitalInitiated CoverageBuy$16.00Medium
9/30/2021Telsey Advisory GroupInitiated CoverageOutperform$15.00High
8/16/2021StephensInitiated CoverageOverweight$19.00High
8/16/2021Bank of AmericaInitiated CoverageNeutral$14.00High
8/16/2021Wells Fargo & CompanyInitiated CoverageOverweight$16.00High
8/16/2021Morgan StanleyInitiated CoverageEqual Weight$14.50High
8/16/2021The Goldman Sachs GroupInitiated CoverageBuy$28.00High
8/16/2021BMO Capital MarketsInitiated CoverageOutperform$24.00High
(Data available from 4/25/2019 forward)

News Sentiment Rating

0.67 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/28/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/28/2023
  • 2 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
11/27/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/27/2023
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/26/2024
  • 3 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/25/2024
  • 5 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
3/26/2024
  • 3 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/25/2024

Current Sentiment

  • 3 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Zevia PBC logo
Zevia PBC, a beverage company, develops, markets, sells, and distributes various carbonated beverages in the United States and Canada. It offers soda, energy drinks, organic tea, and kidz drinks. The company offers its products through a network of food, drug, warehouse club, mass, natural, convenience, and e-commerce channels, as well as grocery distributors and natural product stores and specialty outlets. It provides its products under the Zevia brand name. The company was founded in 2007 and is headquartered in Encino, California.
Read More

Today's Range

Now: $0.83
Low: $0.81
High: $0.89

50 Day Range

MA: $1.23
Low: $0.83
High: $1.73

52 Week Range

Now: $0.83
Low: $0.80
High: $4.80

Volume

86,625 shs

Average Volume

153,238 shs

Market Capitalization

$59.33 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.56

Frequently Asked Questions

What sell-side analysts currently cover shares of Zevia PBC?

The following equities research analysts have issued reports on Zevia PBC in the last year: BMO Capital Markets, Morgan Stanley, Stephens, Telsey Advisory Group, The Goldman Sachs Group, Inc., and Wells Fargo & Company.
View the latest analyst ratings for ZVIA.

What is the current price target for Zevia PBC?

6 Wall Street analysts have set twelve-month price targets for Zevia PBC in the last year. Their average twelve-month price target is $4.17, suggesting a possible upside of 404.6%. Stephens has the highest price target set, predicting ZVIA will reach $8.00 in the next twelve months. Morgan Stanley has the lowest price target set, forecasting a price of $2.00 for Zevia PBC in the next year.
View the latest price targets for ZVIA.

What is the current consensus analyst rating for Zevia PBC?

Zevia PBC currently has 4 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ZVIA, but not buy more shares or sell existing shares.
View the latest ratings for ZVIA.

What other companies compete with Zevia PBC?

Other companies that are similar to Zevia PBC include Kezar Life Sciences, Equillium, HCW Biologics, JATT Acquisition and Immix Biopharma. Learn More about companies similar to Zevia PBC.

How do I contact Zevia PBC's investor relations team?

The company's listed phone number is 855-469-3842 and its investor relations email address is [email protected]. The official website for Zevia PBC is www.zevia.com. Learn More about contacing Zevia PBC investor relations.